The Color of Itch; Itch Modification by Color Viewing

• Sponsor: University Hospital, Basel, Switzerland (Other)
• Overall Status: Completed
• CT.gov ID: NCT03928223
• Collaborator: (none)
• Enrollment: 72
• Location: 1
• Actual Duration (Months): 18
• Patients Per Site Per Month: 4

Study Details

Study Description

Brief Summary

Itch is the commonest skin-related symptom. There is increasing evidence that itch can be influenced by visual cues. The impact of colors on itch has not yet been studied.

This study investigates Itch modification by color viewing and whether patients can match or counteract their itch with a color.

Condition or Disease	Intervention/Treatment	Phase
Itch; Pruritus	Other: exploratory survey on Itch modification by color viewing

Study Design

• Study Type: Observational
• Actual Enrollment: 72 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: The Color of Itch; Itch Modification by Color Viewing- an Exploratory Survey
• Actual Study Start Date: Mar 1, 2017
• Actual Primary Completion Date: Aug 31, 2018
• Actual Study Completion Date: Aug 31, 2018

Outcome Measures

Primary Outcome Measures

1. Change in itch intensity [assessed at baseline and again after the patients looked at the "antipruritic" color for 5 minutes]

   Change in itch intensity (measured on a 0-10 Numerical Rating Scale, NRS); 0 = no itch; 10 = most intensive itch

Eligibility Criteria

Criteria

• Ages Eligible for Study: 16 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Dermatology in- and outpatients with itch

Exclusion Criteria:

• color blindness

• lack of time

• lack of German language.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Department of Dermatology, University Hospital Basel	Basel		Switzerland	4031

Sponsors and Collaborators

• University Hospital, Basel, Switzerland

Investigators

• Principal Investigator: Simon Müller, Dr. med, Department of Dermatology, University Hospital Basel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: University Hospital, Basel, Switzerland
• ClinicalTrials.gov Identifier: NCT03928223
• Other Study ID Numbers: Req 2017-1; sp19Mueller4
• First Posted: Apr 26, 2019
• Last Update Posted: Apr 26, 2019
• Last Verified: Apr 1, 2019

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by University Hospital, Basel, Switzerland: contagious itch; Manchester Color Wheel
• Additional relevant MeSH terms: Pruritus

Study Results

No Results Posted as of Apr 26, 2019